- Recent Advances in Melanoma Therapy
- Targeted Treatments and Immunotherapies for Melanoma
- Tailoring Treatments in Melanoma
- Drug Resistance in Melanoma
- Affordability of Melanoma Care
- Melanoma: Treatment-induced Toxicity
- Immunotherapy: A Decade of Improvements in ...
- Should Patients With Melanoma Receive Targeted ...
- Melanoma: Checkpoints in the Pipeline
- Targeting Therapy for Melanoma Subtypes
- Melanoma: Targetable Genes in the Pipeline
- Clinical Trials in Melanoma
Skin Cancer News
Nivolumab With Ipilimumab May Negate Need for Whole Brain Radiotherapy in Melanoma With Brain Metastases
More Skin Cancer Information
Prevention and early detection are the best ways to keep your skin healthy.
This fact sheet offers tips to decrease the risk of malignant melanoma, the fastest growing forms of skin cancer.
This patient fact sheet provides patients with information on the causes of melanoma along with ways to protect against it and find support in the event of a diagnosis.
This patient fact sheet describes risk factors and preventative measures in skin cancer, malignant melanoma.
This fact sheet helps cancer patients learn what they can do to protect themselves from skin cancer.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Overcoming Drug Resistance in the Treatment of Metastatic Breast Cancer
- Future Treatment Modalities in Sarcoma: Insights From ASCO 2017
- Dietary Nutrients and Oncogenic HPV Infections
- Vaccines Targeting Multiple Myeloma Offer Promising Therapeutic Approach
- In Focus: Abemaciclib for Advanced Breast Cancer
- Yoga Improves Sleep Disorders, Fatigue in Patients With Cancer
- Cryosurgery: The Future of Breast Cancer Treatment?
- Nivolumab With Ipilimumab May Negate Need for Whole Brain Radiotherapy in Melanoma With Brain Metastases
- Aldoxorubicin Improves Outcomes in Relapsed/Refractory Sarcoma
- Green Tea and Cancer
- First-line Nivolumab Fails To Prolong Survival in Stage IV NSCLC
- Pembrolizumab Shows Activity Among Some Young Patients With Advanced Sarcoma
- Potential Clinical Benefit in Multigene Hereditary Testing for Patients With Sarcoma
- Q&A With Filippo Montemurro, MD: Considerations for Treatment With Trastuzumab Emtansine
- Early Taxane Switching May Improve PSA Response Rates in Prostate Cancer